Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China

BACKGROUND: To report the clinical outcomes in Chinese patients with primary open-angle glaucoma and ocular hypertension treated with bimatoprost 0.03% therapy. METHODS: Two hundred sixty-three Chinese patients with primary open-angle glaucoma and ocular hypertension who needed initial or additional...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kaidi, Xu, Li, Yuan, Zhilan, Yao, Ke, Zhao, Junmei, Xu, Liang, Fang, Aiwu, Zhang, Mingzhi, Wu, Lingling, Ji, Jian, Hou, Jiamin, Liu, Qing, Sun, Xinghuai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943806/
https://www.ncbi.nlm.nih.gov/pubmed/24568617
http://dx.doi.org/10.1186/1471-2415-14-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943806/
https://www.ncbi.nlm.nih.gov/pubmed/24568617
http://dx.doi.org/10.1186/1471-2415-14-21

Ejemplares similares